[Vascular contrast agents. Definition and potential applications]

Area of Science:

• Radiochemistry and Molecular Imaging
• Vascular Biology
• Diagnostic Imaging Agents

Context:

• Current imaging agents for CT and MRI often distribute within both intra- and extravascular spaces.
• Blood pool agents exhibit a distinct biodistribution confined solely to the vascular compartment post-intravenous administration.
• This unique characteristic differentiates them from conventional uroangiographic or chelated gadolinium contrast agents.

Purpose:

• To highlight the unique biodistribution properties of blood pool agents.
• To differentiate blood pool agents from uroangiographic and Gd-based contrast agents.
• To explore the diagnostic potential of blood pool agents in various clinical applications.

Summary:

• Blood pool agents are designed for intravenous injection, with their distribution exclusively limited to the vascular space.
• Unlike agents used in CT or MRI that mark both intra- and extravascular areas, blood pool agents remain within the vasculature.
• This targeted biodistribution is a key characteristic that distinguishes them from other contrast media.

Impact:

• Enables precise assessment of vascular integrity and blood flow.
• Facilitates the diagnosis of ischemic diseases, including myocardial and cerebral perfusion defects.
• Supports the evaluation and monitoring of endothelial permeability disorders in conditions such as diabetes and tumors.